RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/25332267http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/25332267http://www.w3.org/2000/01/rdf-schema#comment"

Background

Hepatotoxicity is a major side effect of treatment with bosentan in patients with pulmonary hypertension (PH). Bosentan is metabolized by the cytochrome CYP2C9 and inhibits the bile salt export pump, which is encoded by ABCB11. This suggests that genetic variants of CYP2C9 and/or ABCB11 may predispose patients to bosentan-induced liver injury.

Material and methods

PH patients with (n = 23) or without (n = 25) an increase of alanine aminotransferase (ALT) or aspartate-aminotransferase (AST) during bosentan therapy were included in our analysis. Functionally relevant alleles of CYP2C9 and 16 representative variants of ABCB11 were genotyped. Data were analyzed using logistic regression.

Results

Variants of ABCB11 were not associated with bosentan-induced liver injury. In contrast, variant alleles of CYP2C9 were more common in patients with elevated transaminases (allele frequency 52%) compared to controls (allele frequency 24%, P = 0.04, odds ratio 3.5, 95% confidence interval 1.01-11.8).

Conclusion

Our data indicate hepatotoxicity of bosentan from decreased hepatic metabolism due to common variants of CYP2C9."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.org/dc/terms/identifier"doi:10.1016/s1665-2681(19)30983-4"xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Wittenburg H."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Kovacs P."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Rosendahl J."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Mossner J."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Wirtz H."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Seyfarth H.J."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Tennert C."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Ruffert C."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Halank M."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/author"Favreau N."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/name"Ann Hepatol"xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/pages"803-809"xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/title"Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension."xsd:string
http://purl.uniprot.org/citations/25332267http://purl.uniprot.org/core/volume"13"xsd:string
http://purl.uniprot.org/citations/25332267http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/25332267
http://purl.uniprot.org/citations/25332267http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/25332267
http://purl.uniprot.org/uniprot/#_A0A2D1BLU4-mappedCitation-25332267http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25332267
http://purl.uniprot.org/uniprot/#_A0A2D1BPV8-mappedCitation-25332267http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25332267
http://purl.uniprot.org/uniprot/#_A0A7D5UNI7-mappedCitation-25332267http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25332267
http://purl.uniprot.org/uniprot/#_A0A7D5UNN1-mappedCitation-25332267http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25332267
http://purl.uniprot.org/uniprot/#_A0A0A7MA87-mappedCitation-25332267http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25332267